Eupraxia Pharmaceuticals Inc. , a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector.
Eupraxia Pharmaceuticals stock last closed at $9.00, down 0.11% from the previous day, and has increased 194.12% in one year. It has overperformed other stocks in the Biotechnology industry by 2.29 percentage points. Eupraxia Pharmaceuticals stock is currently +235.82% from its 52-week low of $2.68, and -3.43% from its 52-week high of $9.32.
As of Jan 23, 2026, there are 35.96M EPRX shares outstanding. The market value of EPRX is $323.64M. In the past 24 hours, 72,000 EPRX shares were traded.
You need a brokerage account to access the NASDAQ market and buy EPRX shares.
Based on our research, eToro is the best brokerage. Here's why:
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, the next step is to fill out some personal details so you are able to invest in EPRX stock today.
Now that you have opened your account on mobile trading apps, you need to deposit funds:
Check out the video below for more details transferring funds into your new brokerage account.
Once you have figured out the best place to buy Eupraxia Pharmaceuticals stock, it's absolutely critical to evaluate their stock before you buy, so you actually comprehend the risk and opportunity.
WallStreetZen was built to help part-time investors do better fundamental analysis in less time.
You can see all of the due diligence checks on EPRX's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge EPRX's fair value.
Using relative valuations metrics:
You can access more valuation research on EPRX's stock here.
Out of 2 Equities analysts who give ratings on EPRX, the consensus analyst rating on Eupraxia Pharmaceuticals is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Eupraxia Pharmaceuticals stock forecast page.
In the past year, executives and large shareholders at EPRX have not bought or sold any shares.
Get more info about who owns EPRX stock here.
No, Eupraxia Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two primary order types:
Click the Open button and eToro will execute your order.
If you need more help investing in stocks on eToro, watch the how to video below:
Now that you own some shares in EPRX, you'll want to stay up-to-date on your new company.
Put EPRX on a watchlist to see the latest developments about your EPRX stock.
To summarize, here are the 6 steps to buy stock in Eupraxia Pharmaceuticals:
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get updates on your investment in Eupraxia Pharmaceuticals, click the button below.